| Literature DB >> 23632891 |
Changju Qu1, Yadong Liu, Kranthi Kunkalla, Rajesh R Singh, Marzenna Blonska, Xin Lin, Nitin Kumar Agarwal, Francisco Vega.
Abstract
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults. Aberrant activation of Hedgehog (Hh) and nuclear factor (NF)-κB pathways is ubiquitously observed and known to mediate tumor growth, survival, and chemoresistance in DLBCL. Here, we find that activation of Hh signaling is positively correlated with NF-κB pathway in DLBCL tumors, and that smoothened (SMO), the signal transducer subunit of Hh pathway, contributes to NF-κB activation through recruiting G protein subunits Gαi and Gα12 to activate PKCβ/CARMA1/TRAF6/NEMO signaling axis followed by assembling of the CARMA1/BCL10/MALT1/TRAF6 complex to SMO. Moreover, functional inhibition of SMO enhances the cytotoxic effects of NF-κB inhibitor. Altogether, our study reveals a noncanonical Hh signaling pathway in which SMO activates trimeric G proteins and CARMA1-associated signaling complex, leading to NF-κB activation. This signaling cascade contributes to the survival of DLBCL and may serve as a potential target for combination therapies in DLBCL.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23632891 PMCID: PMC3674670 DOI: 10.1182/blood-2012-12-470153
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113